Fig. 2
From: Healthcare worker views on antimicrobial resistance in chronic respiratory disease
The burden of antimicrobial resistance (AMR) in chronic respiratory disease. A Frequency that respondents encounter multi-drug resistant (MDR) organisms in respiratory infections. B Frequency that respondents’ treatment options are limited due to AMR in respiratory infections. C Frequency that respondents see patients with respiratory infections clinically deteriorate due to a lack of treatment options as a result of AMR. D The extent to which respondents feel that policymakers in their regions consider AMR in chronic lung disease to be an important topic